Over the last few weeks, we have seen women on both sides of the Atlantic speak out on high-profile health issues.
Demand for Hormone Replacement Therapy is soaring in the UK thanks to TV presenter Davina McCall’s documentaries that have highlighted the challenges women face as they go through the menopause.1 In the US, thousands of women have taken part in protests across the country to demonstrate for the protection of abortion rights after leaked documents showed that the Supreme Court had provisionally voted to overturn the landmark ruling that legalized abortion in America in 1973.2
Away from the spotlight, women are being encouraged to speak more openly about their health issues so that they can learn more about health conditions from each other and their doctors, know where to go for help and support, and feel less isolated as they deal with often harrowing conditions and events, such as endometriosis and miscarriage.
But data from the Talking Medicines PatientMetRx® platform on one particular breast cancer medicine indicate there is still a reluctance amongst postmenopausal women to discuss the specifics of their health on social media despite actively using these platforms to connect with friends, family and their broader networks on a range of other topics.
Talking Medicines AI models analyzed a slice of 11,000 social posts between 2015-2022 related to the breast cancer medicine. Results show that that only 10 percent of the posts shared by the intended patient population – post-menopausal women with hormone receptor-positive or ER negative breast cancer – used precise language to describe their situation.
It’s a worrying trend. More detailed data from individuals collected at a population level could provide healthcare providers with the kinds of information that would enable them to adapt existing treatment pathways and even revise treatment guidelines. This could result in women receiving more appropriate care and achieving better outcomes.
As we move forward, it will be important to understand whether women’s reluctance to speak about the specifics of their illness is limited to one medicine or whether this is a broader issue. We will be looking into this in our next blog.
This article has been authored by Roma English Owen, Sales Data Analyst at Talking Medicines. Powered by PatientMetRx® data platform; copyright Talking Medicines 2022. For further information contact email@example.com.
Image sourced by ShutterStock